News

EU Regulator Green Lights an Injectable HIV Drug That Could Help Stop Transmission
LONDON (AP) — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing ...
EU regulator backs Gilead's twice-yearly injection for HIV prevention
The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacapavir, a twice-yearly injection, for ...
A global HIV/AIDS program that saved millions of lives faces cuts under the Trump administration
The Republican-led Senate rescued funding for PEPFAR in a package of spending cuts last month, but the HIV-prevention program ...
Medscape21h
New Injectable Recommended by Europe for HIV Prevention
The drug is administered subcutaneously twice a year, making it easier for high-risk patients to comply with prophylaxis.
Science Daily2d
A deadly virus no one talks about — and the HIV drugs that might stop it
HIV antivirals may be the key to stopping HTLV-1, a deadly virus with no cure. In a decade-long study, researchers ...
KHQ2d
FDA approves 100% effective HIV treatment years after Spokane clinical trials
The FDA has approved a twice-yearly injection for HIV prevention following a groundbreaking clinical trial. Years before the ...
Medscape3d
PEPFAR Spared, but Concerns About Global HIV Response Remain
Experts welcome the news that PEPFAR funding remains intact, but few details about how and where services will be ...
Groups that support LGBTQ+ individuals brace for funding cuts that could affect HIV care, prevention
Chicago-area groups that support LGBTQ+ individuals are navigating an uncertain landscape while bracing for federal funding ...
Federal judge blocks Idaho from verifying immigration status for HIV program
A federal judge on Thursday extended a temporary legal block that prevents Idaho from verifying the immigration status of ...